Annals of Indian Academy of Neurology
  Users Online: 1035 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
This article has been cited by
1Exacerbation history is associated with medication and appointment adherence in MS
Laura M. Hancock,Jared M. Bruce,Sharon G. Lynch
Journal of Behavioral Medicine.2011;34(5)330
2Therapies for multiple sclerosis: considerations in the pediatric patient
Brenda Banwell,Amit Bar-Or,Gavin Giovannoni,Russell C. Dale,Marc Tardieu
Nature Reviews Neurology.2011;7(2)109
3Therapies for multiple sclerosis: considerations in the pediatric patient
David Williams,Lila Mayahi
Nature Reviews Neurology.2012;7(2)189
4Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis
Jagadeswara R. Earla,George J. Hutton,Douglas J. Thornton,Hua Chen,Michael L. Johnson,Rajender R. Aparasu
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2021;41(5)440
5Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group
Peter Rieckmann,Alexey Boyko,Diego Centonze,Irina Elovaara,Gavin Giovannoni,Eva Havrdová,Otto Hommes,Jurg Kesselring,Gisela Kobelt,Dawn Langdon,Jacques LeLorier,Sarah A Morrow,Celia Oreja-Guevara,Sven Schippling,Christoph Thalheim,Heidi Thompson,Patrick Vermersch
Multiple Sclerosis and Related Disorders.2015;4(3)202
6Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability
George A. Jelinek,Tracey J. Weiland,Emily J. Hadgkiss,Claudia H. Marck,Naresh Pereira,Dania M. van der Meer
Neurological Research.2015;37(8)662
  About this journal 
  Editorial Board 
  Online Submission 
  Current Issue 
  Ahead of print 
  Instructions to Authors 

Submit Articles


Join us